Purpose: There is a relatively higher risk of peri-procedural stroke following elective stenting of patients with basilar artery (BA) occlusion compared with stenting of intracranial arteries. We sought to diagnose stroke risks in patients with BA steno-occlusive disease by describing their clinicoradiological features and by demonstrating that appropriate treatment would lead to favorable outcomes. Materials and Methods: A total of 92 patients who were treated from 2004 to 2016 for severe stenosis or occlusion of BA based on MR or CT angiography were enrolled in the study. We assessed clinical features, radiologic findings, and other clinical outcomes such as the degree of disability as determined by the modified Rankin Scale. Results: A total of 49 of the 92 patients (53.3%) had no relevant symptoms. The risk of a recurrent or new infarct in the relevant area was 4.59%/year. Following treatment, more than 50% of the 92 patients had favorable outcomes. A recurrent or new infarct was found in 9 (20.5%) of the 44 patients who had a poor prognosis. There was no significant difference between the two groups with respect to compromised circulation; however, the initial infarct (16 of 48 and 29 of 44, p = 0.002) was statistically significant between the two groups. Conclusion: Atherosclerotic BA steno-occlusion disease is associated with a relatively low risk of a recurrent or new infarct and with favorable clinical outcomes following appropriate medical treatment. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
INTRODUCTION
Atherosclerotic steno-occlusive disease of intracranial arteries is one of the most common causes of ischemic strokes; ongoing debates center around treatment options (1) (2) (3) . A recent clinical trial, the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis (SAMMPRIS) study by Derdeyn et al. (4) , showed that early, aggressive medical management is more beneficial than stenting for high-risk patients with atherosclerotic intracranial stenosis, which per-sists over an extended follow-up period. Angioplasty and stenting were associated with a higher than expected rate of perioperative stroke in this trial (5) . We found vertebrobasilar artery stenosis, in particular, to be the factor with the highest hazard ratio for ischemic stroke in the region of the stented artery (6, 7) .
The postulated pathophysiological mechanism is perforator occlusion i.e., forceful displacement of the disrupted atheromatous debris squashed into the ostia by the stent (6, 8) .
There have been a number of small studies showing that patients with vertebrobasilar artery occlusive disease had a rela- tively benign clinical course (9) (10) (11) . A possible explanation for these results may be that collateral circulation had the potential to maintain adequate perfusion to the posterior fossa after progressive stenosis (9, (11) (12) (13) .
Therefore, one has to consider that there is a higher risk sk of peri-procedural ischemic stroke when using angioplastic procedures involving the basilar artery (BA) compared to other intracranial arteries. Since progressive steno-occlusion of the vertebrobasilar artery is associated with a benign disease course, successful medical treatment, rather than stenting, can provide the most benefit to patients with BA atherosclerotic steno-occlusive disease. This hypothesis can be tested by analyzing studies focused on medically treated atherosclerotic steno-occlusion of the BA. We obtained data regarding clinicoradiological features and outcomes of patients with BA atherosclerotic stenoocclusive disease. At follow-up visits, we also evaluated radiological factors affecting their clinical outcomes. These results will be helpful for predicting outcomes and establishing more suitable treatment strategies.
MATERIALS AND METHODS

Patients
We retrospectively reviewed the clinical and imaging database of 132 symptomatic or asymptomatic patients diagnosed with steno-occlusive disease of the BA. These patients were admitted to or had visited a tertiary hospital between January 2004 and July 2016 and had available follow-up data for more than two months. This study was approved by the Institutional Re- 
Clinical Evaluation
We documented patient demographics, including sex, age, ing a review by phone of each medical record. We defined a favorable outcome as an mRS score ≤ 2 (i.e., unable to carry out all previous activities, but able to look after own affairs without assistance). We defined a poor outcome (overall poor outcome) as an mRS score ≥ 3 (i.e., requiring some help, but able to walk without assistance). We considered an outcome to be relevant when clinical symptoms and outcomes were correlated with radiologic findings at the last follow-up examination. That is, among patients with poor prognosis, we excluded those who had other causes that could affect the clinical outcome, such as anterior circulation infarction, cancer, or trauma other than posterior circulation ischemia, from the relevant poor-outcome group.
Radiological Evaluation
We performed MR imaging using a 3T system (Achieva; Philips Healthcare, Best, Netherlands) and a phased array head coil with sensitivity encoding. We obtained time-of-flight MR angiograms and contrast material-enhanced angiography as well as conventional MR images. A 64-slice computed tomography scanner (Brilliance CT 64 Slice, Siemens, Forchheim, Germany) for CT angiography. We reviewed the images using reformats and maximum intensity projections in multiple planes. For situations in which we could not precisely evaluate the degree or underlying pathologic disease of BA steno-occlusion on MR or CT angiography, we confirmed and distinguished intracranial dissection from atherosclerosis using high-resolution MR imaging (HRMRI) or catheter angiography. We performed HRMRI for the evaluation of the vessel wall using two-dimensional proton density-weighted imaging and the black-blood technique, which was available for 30 patients.
We evaluated the anatomical characteristics of BA steno-occlusion, including the length and location of the stenosis or occlusion of the BA. We subdivided the lengths of steno-occlusion of the BA into shorter (i.e., shorter than half of the BA's total length) or longer (i.e., longer than half of the BA's total length) lesions. We divided the BA into three equal segments (i.e., proximal, mid, and distal) to determine the range of stenosis or occlusion. We subdivided the location of steno-occlusion into proximal-and-middle, distal, and the whole length of the BA.
We recorded the absence or presence of the posterior communicating artery (PCom), vertebral artery (VA) hypoplasia, and steno-occlusive lesions in the VA. We defined VA hypoplasia using the fourth vertebral segment diameter of ≤ 2.0 mm and a concomitant diameter asymmetry ratio of ≤ 1:1.7 in all of the four vertebral segments. We defined VA steno-occlusion by the luminal diameter of > 50% narrowing or no visible lumen at any site of the VA (Fig. 1 ).
We first reviewed the radiological images separately and then discussed them until consensus was reached by two radiologists (L.Y-J and S.G.H) for the discrepant cases.
Statistics
We used the chi-squared test for comparison of clinical presentations, radiological findings, recurrent infarct rates, and clini- cal outcomes between the symptomatic and asymptomatic groups and between the favorable and poor outcome groups.
We defined the statistical significance threshold as a p-value < 0.05.
RESULTS
The study group consisted of 37 men (40.2%) and 55 women (Table 3) . These values were not statistically different between the symptomatic and asymptomatic groups (27 of 43 and 34 of 49, respectively; p = 0.504) ( Table 2) and revealed no statistically significant differences between the favorable and poor outcome groups (21 of 48, 43.8% and 14 of 44, 31.8%, respectively, for undetectable PCom; p = 0.239, 23 of 48, 47.9%, and 22 of 44, 50.0%, respectively, for VA steno-occlusion; p = 0.842 and 8 of 48, 16.7%, and 12 of 44, 27.3%, respectively, for VA hypoplasia; p = 0.218) ( Table 3 ). However, infarct on initial examination was significantly associated with poor outcome (p = 0.002 and p = 0/016, respectively). These findings were similar whether overall or relevant to a poor outcome (Table 3 ). (14) . This was why we evaluated the location of BA steno-occlusion by dividing the locations of steno-occlusion into three segments (i.e., proximal- and-middle, distal, and the whole length of the BA). Distal BA steno-occlusion showed less favorable outcomes than proximaland-middle type. Better outcomes could result from the BA steno-occlusion, through sufficient revascularization strategies to establish collateral circulation,. In addition, non-invasive diagnostic methods such as CT or MR angiography are now better able to detect subclinical or asymptomatic BA steno-occlusions prior to early neurologic deterioration (15) . Therefore, the prognosis of BA steno-occlusion is more diverse and benign than was previously thought (14) . Our study also shows more than 50% of This statistic is comparable to the study by Abuzinadah et al. (16) , in which the stroke recurrence rate in the symptomatic vertebrobasilar stenosis group who were treated medically was 9.6%/year and in the endovascular group was 7.2%/year. Vertebrobasilar stenosis is associated with a stroke recurrence risk that varies between 2.5-5.5% and 10-15% per year (17) . Our study supported the hypothesis that BA atherosclerotic stenoocclusion might have a relatively benign clinical course with the aid of only medical management. In keeping with this conclusion, our results showed a lower stroke recurrence rate compared to that of previous studies that supported the efficacy and safety of medical treatment over stenting.
DISCUSSION
Numerous studies have been performed to examine the prognostic factors for acute BA stroke. In a study by Poletti et al. (18) , of all the CT signs analyzed for patients with BA occlusion, only the presence of signs of acute ischemia on the admission CT was associated with poor prognosis. In a recent study by Lee et al. (19) , for medically treated symptomatic BA stenosis, MR imaging parameters such as hyperintense proximal BA at fluidattenuated inversion recovery imaging and the diffusion weighted posterior circulation Alberta Stroke Program Early CT Score had independent prognostic values for early neurologic deterioration and long-term outcomes. We discovered that the presence of an initial infarct lesion on imaging scans was statistically different in favorable and poor outcome groups and could be radiologic prognostic factors for medically treated patients with atherosclerotic BA steno-occlusion. This result will help to establish management strategies for atherosclerotic BA steno-occlusion. However, further study to search for multiple radiologic predictors for clinical outcomes of patients with BA steno-occlusion is required.
A few limitations of the present study should be addressed. and increase the mRS score.
In conclusion, our study demonstrated that patients with atherosclerotic BA steno-occlusion have a relatively low annual risk of recurrent or new infarct and have favorable outcomes when they receive appropriate medical treatment. Given these data and considering the higher peri-procedural risk in procedures involving BA steno-occlusion compared to procedures involving anterior circulation, medical treatment would be preferred over stenting in patients with atherosclerotic BA steno- 
